These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20130980)

  • 21. Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer.
    Mostert B; Sleijfer S; Foekens JA; Gratama JW
    Cancer Treat Rev; 2009 Aug; 35(5):463-74. PubMed ID: 19410375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BM micrometastases and circulating tumor cells in breast cancer patients: where have we been, where are we now and where does the future lie?
    Müller V; Pantel K
    Cytotherapy; 2005; 7(6):478-82. PubMed ID: 16306009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial.
    Pierga JY; Bidard FC; Mathiot C; Brain E; Delaloge S; Giachetti S; de Cremoux P; Salmon R; Vincent-Salomon A; Marty M
    Clin Cancer Res; 2008 Nov; 14(21):7004-10. PubMed ID: 18980996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
    Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
    Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating tumor cells: will they be clinically useful?
    Nelson NJ
    J Natl Cancer Inst; 2010 Feb; 102(3):146-8. PubMed ID: 20107163
    [No Abstract]   [Full Text] [Related]  

  • 27. Quantification and phenotypic characterization of circulating tumor cells for monitoring response to a preventive HER2/neu vaccine-based immunotherapy for breast cancer: a pilot study.
    Stojadinovic A; Mittendorf EA; Holmes JP; Amin A; Hueman MT; Ponniah S; Peoples GE
    Ann Surg Oncol; 2007 Dec; 14(12):3359-68. PubMed ID: 17906897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Circulating stem cells: a comparison of breast cancer and cardiovascular pathology].
    Bershteĭn LM
    Vopr Onkol; 2009; 55(5):528-33. PubMed ID: 20020646
    [No Abstract]   [Full Text] [Related]  

  • 29. ["Prognostic factors" in breast cancer--1].
    Brockmann B; Reitzig P
    Z Arztl Fortbild (Jena); 1994 Feb; 88(2):111-4. PubMed ID: 8147017
    [No Abstract]   [Full Text] [Related]  

  • 30. Biomarker studies and other difficult inferential problems: statistical caveats.
    Berry DA
    Semin Oncol; 2007 Apr; 34(2 Suppl 3):S17-22. PubMed ID: 17512432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble VCAM-1 and E-selectin in breast cancer: relationship with staging and with the detection of circulating cancer cells.
    Silva HC; Garcao F; Coutinho EC; De Oliveira CF; Regateiro FJ
    Neoplasma; 2006; 53(6):538-43. PubMed ID: 17167725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating tumor cells in solid tumor in metastatic and localized stages.
    Maestro LM; Sastre J; Rafael SB; Veganzones SB; Vidaurreta M; Martín M; Olivier C; DE La Orden VB; Garcia-Saenz JA; Alfonso R; Arroyo M; Diaz-Rubio E
    Anticancer Res; 2009 Nov; 29(11):4839-43. PubMed ID: 20032444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?
    Lang JE; Hall CS; Singh B; Lucci A
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1463-72. PubMed ID: 17944570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients.
    Soria JC; Gauthier LR; Raymond E; Granotier C; Morat L; Armand JP; Boussin FD; Sabatier L
    Clin Cancer Res; 1999 May; 5(5):971-5. PubMed ID: 10353728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating tumor cells, disease progression, and survival in metastatic breast cancer.
    Cristofanilli M
    Semin Oncol; 2006 Jun; 33(3 Suppl 9):S9-14. PubMed ID: 16797376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic and predictive value of HER2 extracellular domain in metastatic breast cancer treated with lapatinib and paclitaxel in a randomized phase III study.
    Finn RS; Gagnon R; Di Leo A; Press MF; Arbushites M; Koehler M
    J Clin Oncol; 2009 Nov; 27(33):5552-8. PubMed ID: 19858400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer.
    Fabjani G; Tong D; Wolf A; Roka S; Leodolter S; Hoecker P; Fischer MB; Jakesz R; Zeillinger R
    Oncol Rep; 2005 Sep; 14(3):737-41. PubMed ID: 16077985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical value of serum tumour markers TPA, TPS, TAG 12, CA 15-3 and MCA in breast cancer diagnosis; results from a prospective study.
    Eskelinen M; Hippeläinen M; Kettunen J; Salmela E; Penttilä I; Alhava E
    Anticancer Res; 1994; 14(2B):699-703. PubMed ID: 8010729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
    Xu Y; Yao L; Li H; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Larsson O; Xie Y
    Breast Cancer Res Treat; 2006 May; 97(1):49-55. PubMed ID: 16319978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measuring circulating tumor cells as a surrogate end point for adjuvant therapy of breast cancer: what do they mean and what should we do about them?
    Bear HD
    J Clin Oncol; 2008 Mar; 26(8):1195-7. PubMed ID: 18323543
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.